News
ARAY
2.200
-3.93%
-0.090
Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System
Accuray Incorporated (NASDAQ: ARAY) announced today that the Oscar Lambret Center in Lille, France has installed its second Radixact® System and the hospital's fifth Accuray radiation therapy delivery system. The hospital has enhanced both Radixact Systems...
PR Newswire · 11/16 12:35
Accuray First Quarter 2023 Earnings: Misses Expectations
Accuray ( NASDAQ:ARAY ) First Quarter 2023 Results Key Financial Results Revenue: US$96.5m (down 10% from 1Q 2022). Net...
Simply Wall St. · 11/09 10:45
Accuray GAAP EPS of -$0.06 misses by $0.02, revenue of $96.49M misses by $3.45M
Seekingalpha · 11/02 20:44
Accuray Reaffirms FY23 Guidance
Benzinga · 11/02 20:42
Accuray Q1 EPS $(0.06) Misses $(0.02) Estimate, Sales $96.49M Miss $100.27M Estimate
Benzinga · 11/02 20:41
-- Earnings Flash (ARAY) ACCURAY INCORPORATED Reports Q1 Revenue $96.5M
-- Earnings Flash (ARAY) ACCURAY INCORPORATED Reports Q1 Revenue $96.5M
MT Newswires · 11/02 16:11
Accuray stock rises on filing for China approval of radiation therapy system
Seekingalpha · 11/01 13:01
Accuray Announces TomoC Registration Submission To China's National Medical Products Administration
Benzinga · 11/01 11:40
Baxter (BAX) Q3 Earnings Meet Estimates, Hilrom Adds $735 M
Baxter's (BAX) third-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.
Zacks · 10/27 16:32
Accuray gains on health insurance reimbursement for radiosurgery system in Japan
Seekingalpha · 10/26 13:32
BRIEF-New Reimbursement Approved By The Japanese Ministry Of Health, Labor And Welfare For The Accuray Cyberknife® System To Treat Trigeminal Neuralgia, A Condition Often Causing Severe Facial Pain
Reuters · 10/26 12:12
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/26 12:06
Accuray Receives Reimbursement Approval in Japan for CyberKnife System to Treat Trigeminal Neuralgia
Accuray Receives Reimbursement Approval in Japan for CyberKnife System to Treat Trigeminal Neuralgia
MT Newswires · 10/26 11:55
Accuray Announces Japanese Ministry Of Health, Labor And Welfare Has Approved Reimbursement Of Cyberknife System
Benzinga · 10/26 11:39
Catalyst Watch: Tech heavyweights report, Mobileye IPO and Twitter-Tesla-Musk drama redux
Seekingalpha · 10/21 18:00
GE Healthcare And Accuray Collaborate To Expand Access, Advance The Practice Of Precision Radiation Therapy
Benzinga · 10/21 16:02
GE Healthcare, Accuray Collaborate to Develop Personalized Radiation Options for Cancer Patients
GE Healthcare, Accuray Collaborate to Develop Personalized Radiation Options for Cancer Patients
MT Newswires · 10/21 12:43
Accuray Incorporated (NASDAQ:ARAY) is largely controlled by institutional shareholders who own 60% of the company
Every investor in Accuray Incorporated ( NASDAQ:ARAY ) should be aware of the most powerful shareholder groups. The...
Simply Wall St. · 10/20 11:55
Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2023, ended September 30, 2022, after the market close on November 2, 2022. Management will host a conference call to review the results at 1:30 p.m. PT ...
PR Newswire · 10/19 20:05
Sun Nuclear Partners With Accuray To Develop New Quality Management Solutions For The Radixact System With Synchrony
 Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE:MIR) ("Mirion"), today announced that it is developing new Quality Management solutions, in collaboration with Accuray, for the
Benzinga · 10/19 12:36
More
Webull provides a variety of real-time ARAY stock news. You can receive the latest news about Accuray Incorp through multiple platforms. This information may help you make smarter investment decisions.
About ARAY
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.